Chinese Medicine Regulates NLRP3 Inflammasomes to Treat Diabetic Nephropathy： A Review
10.13422/j.cnki.syfjx.20231495
- VernacularTitle:中医药调控NLRP3炎症小体治疗糖尿病肾病的研究进展
- Author:
Zhe ZHAO
1
;
Min BAI
1
;
Yuqiu JIN
1
;
Mengyuan TIAN
1
;
Guangshun CHEN
1
;
Zhenhua LIU
1
Author Information
1. Gansu University of Chinese Medicine，Lanzhou 730000，China
- Publication Type:Journal Article
- Keywords:
Chinese medicine;
diabetic nephropathy;
NLRP3 inflammasome;
pyroptosis;
autophagy;
renal fibrosis
- From:
Chinese Journal of Experimental Traditional Medical Formulae
2023;29(23):197-206
- CountryChina
- Language:Chinese
-
Abstract:
Diabetic nephropathy （DN）， a major cause of chronic kidney disease （CKD）， aggravates the prevalence of end-stage renal disease （ESRD） and threatens human health. The pathogenesis of DN is complex， in which inflammation is a key pathological link in the cascade injury. Therefore， the treatment targeting inflammation helps to delay the progression of DN. NOD-like receptor protein 3 （NLRP3）， a classical proteasome， acts as an inducer of innate immune responses. The activated NLRP3 inflammasomes produce and release inflammatory mediators to trigger pyroptosis and uncontrolled autophagy and mediate the stress signals promoting renal fibrosis， thus participating in the development and progression of DN. The NLRP3 inflammasome as a core site inducing inflammation is widely involved in DN progression and may be a novel target. The active components and compound prescriptions of Chinese medicines are increasingly applied in the prevention and treatment of DN. The latest studies have discovered that Chinese medicines can treat DN by regulating the activation of NLRP3 inflammasomes. Although studies have been conducted to explore the mechanism of Chinese medicines in the treatment of DN via NLRP3 inflammasome， the systematic review remains to be carried out. This paper reviews the relevant publications in recent years and introduces the research progress from the assembly and activation of NLRP3 inflammasomes， the mechanism of NLRP3 inflammasomes in the treatment of DN， and the regulation of NLRP3 inflammasomes by Chinese medicines for the prevention and treatment of DN， aiming to lay a foundation for the relevant studies and provide new targets and strategies for the prevention and treatment of DN.
